Published online Nov 25, 2022. doi: 10.5501/wjv.v11.i6.477
Peer-review started: April 20, 2022
First decision: May 31, 2022
Revised: June 12, 2022
Accepted: September 21, 2022
Article in press: September 21, 2022
Published online: November 25, 2022
Processing time: 216 Days and 21.1 Hours
The exponential rise in Coronavirus disease 2019 (COVID-19) cases has resulted in an increased number of patients requiring prolonged ventilatory support and subsequent tracheostomy. With the limited availability of literature regarding the outcomes of COVID-19 patients with tracheostomy, we attempted to study the clinical characteristics and multiple parameters affecting the outcomes in these patients.
To determine all-cause mortality following tracheostomy and its association with various risk factors in COVID-19 patients.
This retrospective study included 73 adult COVID-19 patients admitted to the ICU between 1 April, 2020 and 30 September, 2021 who underwent tracheostomy as a result of acute respiratory failure due to COVID-19. The data collected included demographics (age, sex), comorbidities, type of oxygen support at admission, severity of COVID-19, complications, and other parameters such as admission to tracheostomy, intubation to tracheostomy, ICU stay, hospital stay, and outcome.
This study included 73 adult patients with an average age of 52 ± 16.67 years, of which 52% were men. The average time for admission to tracheostomy was 18.12 ± 12.98 days while intubation to tracheostomy was 11.97 ± 9 days. The mortality rate was 71.2% and 28.8% of patients were discharged alive. The mean duration of ICU and hospital stay was 25 ± 11 days and 28.21 ± 11.60 days, respectively. Greater age, severe COVID-19, mechanical ventilation, shock and acute kidney injury were associated with poor prognosis; however, early tracheostomy in intubated patients resulted in better outcomes.
Patients with severe COVID-19 requiring mechanical ventilation have a poor prognosis but patients with early tracheostomy may benefit with no added risk. We recommend that the timing of tracheostomy be decided on a case-by-case basis and a well-designed randomised controlled trial should be performed to elucidate the potential benefit of early tracheostomy in such patients.
Core Tip: Tracheostomies are commonly performed in critically ill patients who require mechanical ventilation for a prolonged duration. Various recommendations and guidelines have been published regarding the safety of tracheostomy in Coronavirus disease 2019 (COVID-19) patients but literature with respect to indication, timing and outcome of tracheostomy in COVID-19 patients is still lacking. Therefore, in this study we aimed to describe the clinical characteristics of patients who underwent elective tracheostomies and multiple parameters affecting the outcomes in these patients. We found that patients with severe COVID-19 requiring mechanical ventilation had a poor prognosis but patients with early tracheostomy may benefit from this procedure.